estradiol 0.1 MG/24HR Twice Weekly Transdermal Patch

RxCUI
242892
RxNorm name
estradiol 0.1 MG/24HR Twice Weekly Transdermal Patch
Display name
estradiol 0.1 MG/24HR Twice Weekly Transdermal Patch
Full name
estradiol 0.1 MG/24HR Twice Weekly Transdermal Patch
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:04

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 13 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EstradiolESTRADIOLMylan Pharmaceuticals Inc.f4efb0bf-b96f-4e20-a0f2-0806ab92b2d42025-06-23Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 242892
EstradiolESTRADIOLMylan Pharmaceuticals Inc.d28bec8f-762e-4f05-a20d-96a42970d6a72025-06-17Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 242892
DOTTIESTRADIOLBryant Ranch Prepack779751dc-243a-4dc2-ae67-3669f196b2052024-08-12Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 242892
EstradiolESTRADIOLAmneal Pharmaceuticals NY LLCd4259bb8-91f8-4587-8ceb-35d44145aec02024-05-15Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 242892
LYLLANAESTRADIOLAmneal Pharmaceuticals LLC09c472c6-a38a-4a3d-b048-6fefd52e2ad32024-05-15Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 242892
EstradiolESTRADIOLAmneal Pharmaceuticals NY LLC0500ee9b-bf4a-4432-9afe-20a7d60a6fe52024-05-14Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 242892
DOTTIESTRADIOLAmneal Pharmaceuticals LLC53016d30-6b5f-49da-ac16-85ef415a58052024-05-14Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 242892
EstradiolESTRADIOLNoven Therapeutics, LLCbf185599-2138-4083-9c52-2b95dce09ae02024-04-05Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 242892
EstradiolESTRADIOLZydus Pharmaceuticals USA Inc.839fe7ae-6835-4d6a-b6b1-ca7f062caa4f2024-03-15Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 242892
EstradiolESTRADIOLSandoz Incc4da6de7-9ab1-4fcf-88f3-fe785019e6e72024-02-29Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 242892
MinivelleESTRADIOLNoven Therapeutics, LLC6c5c47ab-28ee-11e1-bfc2-0800200c9a662024-02-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 242892
Vivelle-DotESTRADIOLSandoz Inc5ccb77f9-d47b-4381-ad5c-5b92524e1c4a2023-11-17Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 242892
EstradiolESTRADIOLZydus Lifesciences Limitedb79fd5ea-962f-491c-b670-40efe42ccf792022-12-07Exact identifier
rxcui: 242892

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
779751dc-243a-4dc2-ae67-3669f196b205estradiol 0.00417 MG/HR 84 HR Transdermal PatchSY102These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240812
779751dc-243a-4dc2-ae67-3669f196b205estradiol 0.1 MG/Day Twice Weekly Transdermal SystemPSN102These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240812
779751dc-243a-4dc2-ae67-3669f196b205estradiol 0.1 MG/Day Twice Weekly Transdermal SystemSY102These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240812
779751dc-243a-4dc2-ae67-3669f196b205estradiol 0.1 MG/24HR Twice Weekly Transdermal PatchSY102These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240812
779751dc-243a-4dc2-ae67-3669f196b20584 HR estradiol 0.00417 MG/HR Transdermal SystemSCD102These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240812
6c5c47ab-28ee-11e1-bfc2-0800200c9a6684 HR estradiol 0.00417 MG/HR Transdermal SystemSCD19These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 197520240222
6c5c47ab-28ee-11e1-bfc2-0800200c9a66estradiol 0.00417 MG/HR 84 HR Transdermal PatchSY19These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 197520240222
6c5c47ab-28ee-11e1-bfc2-0800200c9a66estradiol 0.1 MG/Day Twice Weekly Transdermal SystemSY19These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 197520240222
6c5c47ab-28ee-11e1-bfc2-0800200c9a66estradiol 0.1 MG/Day Twice Weekly Transdermal SystemPSN19These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 197520240222
6c5c47ab-28ee-11e1-bfc2-0800200c9a66estradiol 0.1 MG/24HR Twice Weekly Transdermal PatchSY19These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 197520240222
0500ee9b-bf4a-4432-9afe-20a7d60a6fe5estradiol 0.1 MG/Day Twice Weekly Transdermal SystemPSN17These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 199620240514
0500ee9b-bf4a-4432-9afe-20a7d60a6fe5estradiol 0.00417 MG/HR 84 HR Transdermal PatchSY17These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 199620240514
0500ee9b-bf4a-4432-9afe-20a7d60a6fe584 HR estradiol 0.00417 MG/HR Transdermal SystemSCD17These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 199620240514
0500ee9b-bf4a-4432-9afe-20a7d60a6fe5estradiol 0.1 MG/24HR Twice Weekly Transdermal PatchSY17These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 199620240514
0500ee9b-bf4a-4432-9afe-20a7d60a6fe5estradiol 0.1 MG/Day Twice Weekly Transdermal SystemSY17These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 199620240514
5ccb77f9-d47b-4381-ad5c-5b92524e1c4aestradiol 0.1 MG/Day Twice Weekly Transdermal SystemPSN17These highlights do not include all the information needed to use VIVELLE-DOT safely and effectively. See full prescribing information for VIVELLE-DOT. VIVELLE-DOT ® (estradiol transdermal system) Initial U.S. Approval: 199620231117
5ccb77f9-d47b-4381-ad5c-5b92524e1c4a84 HR estradiol 0.00417 MG/HR Transdermal SystemSCD17These highlights do not include all the information needed to use VIVELLE-DOT safely and effectively. See full prescribing information for VIVELLE-DOT. VIVELLE-DOT ® (estradiol transdermal system) Initial U.S. Approval: 199620231117
5ccb77f9-d47b-4381-ad5c-5b92524e1c4aestradiol 0.00417 MG/HR 84 HR Transdermal PatchSY17These highlights do not include all the information needed to use VIVELLE-DOT safely and effectively. See full prescribing information for VIVELLE-DOT. VIVELLE-DOT ® (estradiol transdermal system) Initial U.S. Approval: 199620231117
5ccb77f9-d47b-4381-ad5c-5b92524e1c4aestradiol 0.1 MG/Day Twice Weekly Transdermal SystemSY17These highlights do not include all the information needed to use VIVELLE-DOT safely and effectively. See full prescribing information for VIVELLE-DOT. VIVELLE-DOT ® (estradiol transdermal system) Initial U.S. Approval: 199620231117
5ccb77f9-d47b-4381-ad5c-5b92524e1c4aestradiol 0.1 MG/24HR Twice Weekly Transdermal PatchSY17These highlights do not include all the information needed to use VIVELLE-DOT safely and effectively. See full prescribing information for VIVELLE-DOT. VIVELLE-DOT ® (estradiol transdermal system) Initial U.S. Approval: 199620231117
09c472c6-a38a-4a3d-b048-6fefd52e2ad3estradiol 0.1 MG/Day Twice Weekly Transdermal SystemSY15These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 197520240515
09c472c6-a38a-4a3d-b048-6fefd52e2ad3estradiol 0.00417 MG/HR 84 HR Transdermal PatchSY15These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 197520240515
09c472c6-a38a-4a3d-b048-6fefd52e2ad3estradiol 0.1 MG/24HR Twice Weekly Transdermal PatchSY15These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 197520240515
09c472c6-a38a-4a3d-b048-6fefd52e2ad3estradiol 0.1 MG/Day Twice Weekly Transdermal SystemPSN15These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 197520240515
09c472c6-a38a-4a3d-b048-6fefd52e2ad384 HR estradiol 0.00417 MG/HR Transdermal SystemSCD15These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 197520240515
d28bec8f-762e-4f05-a20d-96a42970d6a7estradiol 0.1 MG/24HR Twice Weekly Transdermal PatchSY14These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 199620250617
d28bec8f-762e-4f05-a20d-96a42970d6a7estradiol 0.1 MG/Day Twice Weekly Transdermal SystemPSN14These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 199620250617
d28bec8f-762e-4f05-a20d-96a42970d6a784 HR estradiol 0.00417 MG/HR Transdermal SystemSCD14These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 199620250617
d28bec8f-762e-4f05-a20d-96a42970d6a7estradiol 0.1 MG/Day Twice Weekly Transdermal SystemSY14These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 199620250617
d28bec8f-762e-4f05-a20d-96a42970d6a7estradiol 0.00417 MG/HR 84 HR Transdermal PatchSY14These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 199620250617
d4259bb8-91f8-4587-8ceb-35d44145aec0estradiol 0.1 MG/24HR Twice Weekly Transdermal PatchSY11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 197520240515
d4259bb8-91f8-4587-8ceb-35d44145aec084 HR estradiol 0.00417 MG/HR Transdermal SystemSCD11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 197520240515
d4259bb8-91f8-4587-8ceb-35d44145aec0estradiol 0.1 MG/Day Twice Weekly Transdermal SystemSY11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 197520240515
d4259bb8-91f8-4587-8ceb-35d44145aec0estradiol 0.00417 MG/HR 84 HR Transdermal PatchSY11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 197520240515
d4259bb8-91f8-4587-8ceb-35d44145aec0estradiol 0.1 MG/Day Twice Weekly Transdermal SystemPSN11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 197520240515
c4da6de7-9ab1-4fcf-88f3-fe785019e6e7estradiol 0.1 MG/Day Twice Weekly Transdermal SystemSY11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 199620240229
c4da6de7-9ab1-4fcf-88f3-fe785019e6e7estradiol 0.00417 MG/HR 84 HR Transdermal PatchSY11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 199620240229
c4da6de7-9ab1-4fcf-88f3-fe785019e6e7estradiol 0.1 MG/24HR Twice Weekly Transdermal PatchSY11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 199620240229
c4da6de7-9ab1-4fcf-88f3-fe785019e6e784 HR estradiol 0.00417 MG/HR Transdermal SystemSCD11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 199620240229
c4da6de7-9ab1-4fcf-88f3-fe785019e6e7estradiol 0.1 MG/Day Twice Weekly Transdermal SystemPSN11These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 199620240229
53016d30-6b5f-49da-ac16-85ef415a5805estradiol 0.00417 MG/HR 84 HR Transdermal PatchSY10These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240514
53016d30-6b5f-49da-ac16-85ef415a5805estradiol 0.1 MG/24HR Twice Weekly Transdermal PatchSY10These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240514
53016d30-6b5f-49da-ac16-85ef415a5805estradiol 0.1 MG/Day Twice Weekly Transdermal SystemPSN10These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240514
53016d30-6b5f-49da-ac16-85ef415a5805estradiol 0.1 MG/Day Twice Weekly Transdermal SystemSY10These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240514
53016d30-6b5f-49da-ac16-85ef415a580584 HR estradiol 0.00417 MG/HR Transdermal SystemSCD10These highlights do not include all the information needed to use DOTTI safely and effectively. See full prescribing information for DOTTI. DOTTI ® (estradiol transdermal system) Initial U.S. Approval: 199620240514
f4efb0bf-b96f-4e20-a0f2-0806ab92b2d4estradiol 0.1 MG/Day Twice Weekly Transdermal SystemPSN7These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 197520250623
f4efb0bf-b96f-4e20-a0f2-0806ab92b2d4estradiol 0.1 MG/24HR Twice Weekly Transdermal PatchSY7These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 197520250623
f4efb0bf-b96f-4e20-a0f2-0806ab92b2d4estradiol 0.1 MG/Day Twice Weekly Transdermal SystemSY7These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 197520250623
f4efb0bf-b96f-4e20-a0f2-0806ab92b2d484 HR estradiol 0.00417 MG/HR Transdermal SystemSCD7These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 197520250623
f4efb0bf-b96f-4e20-a0f2-0806ab92b2d4estradiol 0.00417 MG/HR 84 HR Transdermal PatchSY7These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system (twice-weekly) Initial U.S. Approval: 197520250623
bf185599-2138-4083-9c52-2b95dce09ae0estradiol 0.1 MG/Day Twice Weekly Transdermal SystemSY6These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 197520240405
bf185599-2138-4083-9c52-2b95dce09ae0estradiol 0.00417 MG/HR 84 HR Transdermal PatchSY6These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 197520240405
bf185599-2138-4083-9c52-2b95dce09ae0estradiol 0.1 MG/Day Twice Weekly Transdermal SystemPSN6These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 197520240405
bf185599-2138-4083-9c52-2b95dce09ae084 HR estradiol 0.00417 MG/HR Transdermal SystemSCD6These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 197520240405
bf185599-2138-4083-9c52-2b95dce09ae0estradiol 0.1 MG/24HR Twice Weekly Transdermal PatchSY6These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 197520240405
839fe7ae-6835-4d6a-b6b1-ca7f062caa4festradiol 0.1 MG/Day Twice Weekly Transdermal SystemSY4These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system, USP (TWICE-WEEKLY) Initial U.S. Approval: 199620240315
839fe7ae-6835-4d6a-b6b1-ca7f062caa4f84 HR estradiol 0.00417 MG/HR Transdermal SystemSCD4These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system, USP (TWICE-WEEKLY) Initial U.S. Approval: 199620240315
839fe7ae-6835-4d6a-b6b1-ca7f062caa4festradiol 0.00417 MG/HR 84 HR Transdermal PatchSY4These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system, USP (TWICE-WEEKLY) Initial U.S. Approval: 199620240315
839fe7ae-6835-4d6a-b6b1-ca7f062caa4festradiol 0.1 MG/Day Twice Weekly Transdermal SystemPSN4These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system, USP (TWICE-WEEKLY) Initial U.S. Approval: 199620240315
839fe7ae-6835-4d6a-b6b1-ca7f062caa4festradiol 0.1 MG/24HR Twice Weekly Transdermal PatchSY4These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY). ESTRADIOL transdermal system, USP (TWICE-WEEKLY) Initial U.S. Approval: 199620240315
3818d31e-31f6-4a6c-bf2b-41b0299e4500estradiol 0.1 MG/24HR Twice Weekly Transdermal PatchSY1These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 199620231123
3818d31e-31f6-4a6c-bf2b-41b0299e4500estradiol 0.1 MG/Day Twice Weekly Transdermal SystemSY1These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 199620231123
3818d31e-31f6-4a6c-bf2b-41b0299e450084 HR estradiol 0.00417 MG/HR Transdermal SystemSCD1These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 199620231123
3818d31e-31f6-4a6c-bf2b-41b0299e4500estradiol 0.00417 MG/HR 84 HR Transdermal PatchSY1These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 199620231123
3818d31e-31f6-4a6c-bf2b-41b0299e4500estradiol 0.1 MG/Day Twice Weekly Transdermal SystemPSN1These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL TRANSDERMAL SYSTEM Initial U.S. Approval: 199620231123
b79fd5ea-962f-491c-b670-40efe42ccf79estradiol 0.1 MG/24HR Twice Weekly Transdermal PatchSY1ESTRADIOL transdermal system, USP (TWICE-WEEKLY)20221207
b79fd5ea-962f-491c-b670-40efe42ccf79estradiol 0.1 MG/Day Twice Weekly Transdermal SystemSY1ESTRADIOL transdermal system, USP (TWICE-WEEKLY)20221207
b79fd5ea-962f-491c-b670-40efe42ccf7984 HR estradiol 0.00417 MG/HR Transdermal SystemSCD1ESTRADIOL transdermal system, USP (TWICE-WEEKLY)20221207
b79fd5ea-962f-491c-b670-40efe42ccf79estradiol 0.1 MG/Day Twice Weekly Transdermal SystemPSN1ESTRADIOL transdermal system, USP (TWICE-WEEKLY)20221207
b79fd5ea-962f-491c-b670-40efe42ccf79estradiol 0.00417 MG/HR 84 HR Transdermal PatchSY1ESTRADIOL transdermal system, USP (TWICE-WEEKLY)20221207
03ab0226-b494-4607-8e8b-7381082fa78084 HR estradiol 0.00417 MG/HR Transdermal SystemSCD1Vivelle-Dot20120217
03ab0226-b494-4607-8e8b-7381082fa780estradiol 0.1 MG/Day Twice Weekly Transdermal SystemSY1Vivelle-Dot20120217
03ab0226-b494-4607-8e8b-7381082fa780estradiol 0.1 MG/Day Twice Weekly Transdermal SystemPSN1Vivelle-Dot20120217
03ab0226-b494-4607-8e8b-7381082fa780estradiol 0.1 MG/24HR Twice Weekly Transdermal PatchSY1Vivelle-Dot20120217
03ab0226-b494-4607-8e8b-7381082fa780estradiol 0.00417 MG/HR 84 HR Transdermal PatchSY1Vivelle-Dot20120217